Abstract
Fluconazole is a recently licensed antifungal agent that has gained widespread use in the medical community. Despite a lack of controlled trials in invasive fungal infections, this agent is often prescribed because of ease of administration and concern over amphotericin B toxicity. Three cases of systemic fungal infections in which fluconazole use resulted in unambiguous microbiologic and clinical failure are reported.
Original language | English (US) |
---|---|
Pages (from-to) | 1232-1235 |
Number of pages | 4 |
Journal | Journal of Infectious Diseases |
Volume | 164 |
Issue number | 6 |
DOIs | |
State | Published - Dec 1991 |
Externally published | Yes |
ASJC Scopus subject areas
- Immunology and Allergy
- Infectious Diseases